HPMA copolymer conjugates of paclitaxel and docetaxel with pH-controlled drug release

T Etrych, M Šírová, L Starovoytova… - Molecular …, 2010 - ACS Publications
In this paper we describe the synthesis, physicochemical characteristics and data on the
biological activity of polymer prodrugs based on the anticancer drugs paclitaxel (PTX) and …

Preclinical evaluation of linear HPMA-doxorubicin conjugates with pH-sensitive drug release: efficacy, safety, and immunomodulating activity in murine model

M Sirova, T Mrkvan, T Etrych, P Chytil… - Pharmaceutical …, 2010 - Springer
Purpose In vivo efficacy and safety of HPMA-based copolymers armed with doxorubicin via
a spacer containing pH-sensitive linkage that can be prepared within a broad range of …

Synthesis and in vitro efficacy of acid-sensitive poly (ethylene glycol) paclitaxel conjugates

PCA Rodrigues, K Scheuermann, C Stockmar… - Bioorganic & Medicinal …, 2003 - Elsevier
Three maleimide derivatives of the anticancer drug paclitaxel that incorporate an acid-
sensitive carboxylic hydrazone linker were prepared and coupled to bifunctional PEGs (MW …

Properties of HPMA copolymer–doxorubicin conjugates with pH-controlled activation: effect of polymer chain modification

P Chytil, T Etrych, Č Koňák, M Šírová, T Mrkvan… - Journal of controlled …, 2006 - Elsevier
Various conjugates of anticancer drug doxorubicin (DOX) covalently attached via
hydrolytically degradable hydrazone bond to water-soluble N-(2-hydroxypropyl) …

New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties

T Etrych, M Jelı́nková, B Řı́hová, K Ulbrich - Journal of Controlled Release, 2001 - Elsevier
In this paper we describe the synthesis, physico-chemical characteristics and results of tests
of biological activity of polymer drugs based on conjugates of anti-cancer drug doxorubicin …

Nano-sized assemblies of a PEG-docetaxel conjugate as a formulation strategy for docetaxel

J Liu, P Zahedi, F Zeng, C Allen - Journal of pharmaceutical sciences, 2008 - Elsevier
An amphiphilic polymer-drug conjugate was prepared by attachment of low molecular
weight methoxy poly (ethylene glycol)(PEG)(ie, 2 kDa) to docetaxel (DTX) through an ester …

HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity

K Ulbrich, T Etrych, P Chytil, M Jelınková… - Journal of Controlled …, 2003 - Elsevier
Data on the synthesis, physicochemical characterisation and in vitro and in vivo biological
properties of the new, nontargeted or antibody-targeted polymer–doxorubicin conjugates …

Poly-(L)-glutamic acid-paclitaxel (CT-2103)[XYOTAX™], a biodegradable polymeric drug conjugate: Characterization, preclinical pharmacology, and preliminary …

JW Singer, B Baker, P De Vries, A Kumar… - Polymer drugs in the …, 2003 - Springer
Conclusions These data describing the preclinical and early clinical development of CT-
2103 demonstrate the feasibility of using polyglutamic acid homopolymers to create …

Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel

R Zhang, K Luo, J Yang, M Sima, Y Sun… - Journal of Controlled …, 2013 - Elsevier
The performance and safety of current antineoplastic agents, particularly water-insoluble
drugs, are still far from satisfactory. For example, the currently widely used Cremophor EL® …

Polymer-drug conjugates: recent development in clinical oncology

C Li, S Wallace - Advanced drug delivery reviews, 2008 - Elsevier
Targeted drug delivery aims to increase the therapeutic index by making more drug
molecules available at the diseased sites while reducing systemic drug exposure. In this …